Genetics: Prevalence of Turner syndrome in Japan (K. lmaizumi, Y- Kuroki). Mechanisms leading to statural changes in patients with sex chromosome aberrations (T. Ogata, N Marsuo). Genotype-phenotype correlations in the Turner syndrome (M.A. Ferguson-Smith). From chromosomes and genes to the discovery of Turner syndrome secrets (M. L, Giovannucci Uzielli, M. Failli, C. Siondi). Mapping the human Y chromosome (Y. Nakagome, S. Nagafuchi. Y. Nakahori). Neoplasia in Turnersyndrome(A,A. Sandborg). Turner syndrome and the Y chromosome (A.R. Zinn, D.C. Paqe). Chairperson's comments. Natural History (Growth and Organogenesis): Structural defects of the vascular system in 45, X fetuses: Integrated interpretation of the pathogenesis (S. Miyabara et al.). standards for growth and growth velocity in Turner syndrome (S. Suwa). Growth in Turner syndrome: Updating the United States experience (B. Lippe et al,). Reference values for spontaneous growth in Turner girls and its use in estimating treatment effects (J. Karlberg et al.). The natural history of ovarian demise in Turner syndrome (R. Stanhope,A. Massarano, C.G.D. Brook). The pregnancy outcome of Turner syndrome: Case report and review of the literature (S. Kawagoe, N. Kaneko, M Hiroi). Glucose tolerance in Turner syndrome" (T. Tanaka et al.). Chairperson's comments. Endocrine Function and Bone Metabolism: Ovarian functic)n in Turner syndrome: Recognizing the spectrum (B. Lippe, S.J. Westra, M.I. Boechat). Hormonal characteristics of the menstrual cycle in Turner syndrome (H. Maesaka et al.). Thyroid function in Turner syndrome (G. Massa, F. de Zogher, M. Vanderschueren-Lodeweyckx). Calcium and bone metabolism in Ullrich-Turner syndrome before and during HGH treatment (K. Kruse, E. Schdnau). Biglycan synthesis in fibroblasts of patients with Turner syndrome and other sex chromosome anomalies (U. Vetteretal.). Skeletal growth in the Turner syndrome: Cellularand molecular pathogenetic considerations (W.A. Horton). Chairperson's comments. Psychosocial problems: Psychosocial functioning and effects of growth hormone treatment in Tumer syndrome (J. Huisman et al.). Psychosocial functioning in middle-aged women with Turner syndrome (L. Sylven et al.). What more can be done for girls and women with Tumer syndrome (J Nielsen). Follow-up study of 69 Turner women (B. Konradsen, J. Ivielsen). Benefits of support groups for those affected by Turner syndrome and the associated medical community (L.G . Tesch). Chairperson's comments. Gonadal replacement therapy: Treatment of Turner syndrome with transdermal estradiol (Estraderm) (Y. Igarashi et al.). A multi-centre double-blind trial of synthetic growth hormone and low dose oestrogen in Turner syndrome: Two year analysis (G.A. Werther, J. Simpson). Treatment in Turner syndrome with a low dose of peroral 17-B-estradiol alone, or in combination with growth hormone (R.W. Naeraa, K.W. Kastrup, J. Nielsen). Part contents.
